Surplus Solutions, an NMS Capital Portfolio Company, Expands Lab Repair Capabilities, Acquires Boston Industries

New York, NY and Walpole, MA, August 11, 2026 - Surplus Solutions LLC ("Surplus Solutions"), a portfolio company of NMS Capital ("NMS"), announced today the acquisition of Boston Industries ("Boston Industries" or the "Company"), a Walpole, Massachusetts-based specialist in the technical repair and refurbishment of laboratory instruments. The acquisition adds in-house technical service expertise in flow cytometry, microscopy, liquid handling, and other core instrument categories, widening the range of laboratory equipment Surplus Solutions can repair and refurbish directly for its biotechnology, pharmaceutical, and life sciences customers. Terms of the transaction were not disclosed.

Founded in 2013, Boston Industries has spent more than a decade restoring high-value laboratory instruments to full working condition and returning them to labs around the world. Operating from its facility in Walpole, MA, the Company specializes in the repair and refurbishment of liquid-handling robotics, flow cytometry, microscopy and imaging, nucleic acid preparation, and PCR systems. Boston Industries has delivered instruments to customers in more than 45 countries, including biotechnology firms, pharmaceutical companies, academic research institutions, and industrial laboratories, and carries a large inventory of current-model instruments.

"Bringing Boston Industries' team and technical depth into Surplus Solutions makes us the most technically capable reseller in the business - with the combined inventory, transaction volume, and technical support capacity, we're out in front, and we'll keep growing and expanding to get better for our customers," said Joe Reale, CEO, Surplus Solutions.

David Peterson, Partner at NMS, added, "The acquisition of Boston Industries reflects our continued focus on building out Surplus Solutions' technical repair platform, following the acquisition of DCM BioServices earlier this year. Each new repair capability deepens Surplus' relationships with customers in between equipment purchases and widens the range of instruments Surplus can return to market. We are excited to support both teams as this capability takes hold across the platform."

McDermott Will & Schulte provided legal advice to Surplus Solutions. Financing for the transaction was provided by TPG Twin Brook Capital Partners. Merger Nation and Nutter McClennen & Fish served as legal advisor to Boston Industries.

About Surplus Solutions:
Founded in 2006, Surplus Solutions is the leading provider of Equipment Lifecycle Management solutions for the life sciences industry, delivering value across the equipment lifecycle through expert sourcing, resale, refurbishment, relocation, and technical repair and maintenance services. Headquartered in Woonsocket, RI, with operations spanning the U.S. and Europe, Surplus Solutions serves a diverse customer base ranging from emerging biotechs to Fortune 500 pharmaceutical companies, helping organizations maximize asset value, extend equipment lifespan, and bring products to market faster and more cost-effectively. For additional information on Surplus Solutions, please visit the firm's website at ssllc.com.

About Boston Industries:
Founded in 2013 and headquartered in Walpole, MA, Boston Industries is a leading provider of technical repair, refurbishment, and resale services for quality pre-owned laboratory equipment. The Company's services a broad range of instrumentation, including liquid-handling robotics, flow cytometry, microscopy and imaging, nucleic acid preparation, and PCR systems. Serving biotechnology, pharmaceutical, academic, and industrial customers, Boston Industries helps laboratories access fully serviced, current-model instruments. For additional information, please visit www.bostonind.com.

About NMS Capital:
Founded in 2010, NMS Capital is an experienced private equity firm managing assets in excess of $2.0 billion. Since inception, NMS has partnered with management teams in over 150 investments and follow-on acquisitions across defined investment themes within the Business Services and Healthcare Services industries. The firm's principal strategy is to create long-term value by providing strategic and operational resources to growthoriented companies led by founders or experienced management teams. NMS has successfully built industry leading lower middle market companies in defensible and scalable end markets by accelerating organic and acquisition-driven growth.

For additional information on NMS, please visit the firm's website at https://www.nms-capital.com. Follow NMS Capital on https://www.linkedin.com/company/nms-capital.

For further information:
David Peterson
Partner
212.574.7006
[email protected]